Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael F Duarte

Showing results (1-10 of 113) with videos related to

Pageof 12
Sort By:
Future Microbiology|July 8, 2017
Invasive fungal infections: managing the continuum of risk in HCT patientsRafael F Duarte, Sue Lyon
Future Science OA|May 26, 2018
Novel approaches to CMV after HCT: report from the 27th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 22-25 April 2017Rafael F Duarte, Sue Lyon
Thescientificworldjournal|January 25, 2011
Practical aspects of allogeneic hematopoietic cell transplantation for patients with poor-risk chronic lymphocytic leukemiaJulio Delgado, Rafael F Duarte
Leukemia & Lymphoma|August 3, 2002
The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevanceRafael F Duarte, David A Frank
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspectiveKatrien Lagrou, Rafael F Duarte, Johan Maertens
Haematologica|April 2, 2014
Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench storyDonald C Sheppard, Paolo Campoli, Rafael F Duarte
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2015
Reply to Lewis et alRafael F Duarte, Isabel Sánchez-Ortega, Manuel Cuenca-Estrella
The Journal of Antimicrobial Chemotherapy|November 24, 2016
The current management landscape: aspergillosisJohan A Maertens, Ola Blennow, Rafael F Duarte, et al.
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Cancers|November 11, 2022
Monoclonal Gammopathies of Clinical Significance: A Critical AppraisalRafael Ríos-Tamayo, Bruno Paiva, Juan José Lahuerta, et al.
Pageof 12

Showing results (1-10 of 113) with videos related to

Sort By:
Pageof 12
Future Microbiology|July 8, 2017
Invasive fungal infections: managing the continuum of risk in HCT patientsRafael F Duarte, Sue Lyon
Future Science OA|May 26, 2018
Novel approaches to CMV after HCT: report from the 27th European Congress of Clinical Microbiology and Infectious Diseases, Vienna, Austria, 22-25 April 2017Rafael F Duarte, Sue Lyon
Thescientificworldjournal|January 25, 2011
Practical aspects of allogeneic hematopoietic cell transplantation for patients with poor-risk chronic lymphocytic leukemiaJulio Delgado, Rafael F Duarte
Leukemia & Lymphoma|August 3, 2002
The synergy between stem cell factor (SCF) and granulocyte colony-stimulating factor (G-CSF): molecular basis and clinical relevanceRafael F Duarte, David A Frank
The Journal of Antimicrobial Chemotherapy|June 22, 2019
Standards of CARE: what is considered 'best practice' for the management of invasive fungal infections? A haematologist's and a mycologist's perspectiveKatrien Lagrou, Rafael F Duarte, Johan Maertens
Haematologica|April 2, 2014
Understanding antifungal prophylaxis with posaconazole in hematology patients: an evolving bedside to bench storyDonald C Sheppard, Paolo Campoli, Rafael F Duarte
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2015
Reply to Lewis et alRafael F Duarte, Isabel Sánchez-Ortega, Manuel Cuenca-Estrella
The Journal of Antimicrobial Chemotherapy|November 24, 2016
The current management landscape: aspergillosisJohan A Maertens, Ola Blennow, Rafael F Duarte, et al.
Mycoses|March 31, 2016
Invasive fungal infections in AML/MDS patients treated with azacitidine: a risk worth considering antifungal prophylaxis?Helena Pomares, Montserrat Arnan, Isabel Sánchez-Ortega, et al.
Cancers|November 11, 2022
Monoclonal Gammopathies of Clinical Significance: A Critical AppraisalRafael Ríos-Tamayo, Bruno Paiva, Juan José Lahuerta, et al.
Pageof 12